PA
Insider
Peter Anevski
CHIEF EXECUTIVE OFFICERPeter Anevski (CHIEF EXECUTIVE OFFICER) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Progyny, Inc. (PGNY). Across 1 priced purchase filing, the average 21-session return was +12.2% from execution and +2.0% from disclosure (delay-adjusted; derived). The largest single filing was $1.9M of PGNY (79,500 sh × $24.29, as filed), executed Nov 13 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+12.2%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+2.0%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.9M
shares × price, as filed
Last traded
Nov 13 2025
Filed Nov 17 2025
Median ADV $33.4M across their filed names
Open performance→Volume by month
Buys $5.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
PGNYRecent filings
PGNYPURCHASE
Progyny, Inc.
View filing →
$1.9M79,500 sh × $24.29
Exec Nov 13 2025
Filed Nov 17 2025 · 8:22 AM ET PGNYPURCHASE Progyny, Inc. View filing → $3.0M
209,500 sh × $14.48
Exec Dec 23 2024
Filed Dec 26 2024 · 5:30 PM ET